Can We Eat Our Way to a Younger Self? New Research Suggests Diet Shifts May Rewind the Biological Clock on June 20, 2026 Posted by
Arterial Stiffness as a Superior Predictor: A New Paradigm for Cardiovascular Risk Assessment in Rheumatic Patients on June 20, 2026 Posted by
The Hidden Connection: How Chronic Pain Signals a Looming Threat to Cardiovascular Health on June 20, 2026 Posted by
A Silent Crisis: The Mounting Toll of the Bundibugyo Ebola Outbreak in Eastern Congo on June 20, 2026 Posted by
Advancing the Science of Rest: Dr. Fariha Abbasi-Feinberg Takes the Helm at the American Academy of Sleep Medicine on June 20, 2026 Posted by
The Invisible Siege: Unmasking the Threats to Modern Health, Privacy, and Stability on June 20, 2026 Posted by
Can We Eat Our Way to a Younger Self? New Research Suggests Diet Shifts May Rewind the Biological Clock on June 20, 2026 Posted by
Arterial Stiffness as a Superior Predictor: A New Paradigm for Cardiovascular Risk Assessment in Rheumatic Patients on June 20, 2026 Posted by
The Hidden Connection: How Chronic Pain Signals a Looming Threat to Cardiovascular Health on June 20, 2026 Posted by
Posted in Medical Innovations The Next Frontier in Oncology: Jazz Pharmaceuticals and AbCellera Forge Alliance to Advance Multispecific T-Cell Engagers on June 18, 2026
Posted in Digital Health Tools Rocket Pharmaceuticals Bolsters Financial Runway with $180 Million Priority Review Voucher Sale on June 14, 2026
Posted in Medical Innovations Mentari Therapeutics Secures $290M Funding in Strategic Reverse Merger with InMed Pharmaceuticals on May 20, 2026 rifanmuazin
Posted in Medical Innovations Takeda Pharmaceuticals Agrees to $13.6 Million Settlement Over Kickback Allegations Involving Trintellix on May 15, 2026 rifanmuazin
Posted in Respiratory Health Enanta Pharmaceuticals to Unveil Pivotal Respiratory Data at ATS 2026: A Deep Dive into Zelicapavir and EPS-3903 on May 14, 2026 rifanmuazin
Posted in Medical Innovations Angelini Pharma Expands U.S. Footprint with $4.1 Billion Acquisition of Catalyst Pharmaceuticals on May 9, 2026 rifanmuazin
